Are Overweight Children with T1DM at Increased Risk of Cardiovascular Disease?
Are Overweight Children with T1DM at Increased Risk of Cardiovascular Disease?
批准号:
7925687
负责人:
INGRID M LIBMAN
金额:
$13.01万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-06-15 至 2012-05-31
关键词:
AdultAgeAnthropometryAreaAtherosclerosisBlood PressureBlood TestsBody mass indexCardiovascular DiseasesCarotid ArteriesCenter for Translational Science ActivitiesCentral obesityChildChildhoodClinicalCross-Sectional StudiesDEXADataDevelopmentDevelopment PlansDiabetes MellitusDisease MarkerDyslipidemiasEndocrinologistEpidemiologyEuglycemic ClampingFastingGlucose ClampGoalsHourHypertensionImmuneInsulinInsulin ResistanceInsulin-Dependent Diabetes MellitusLifeLipidsMeasurementMeasuresMediatingMentorshipMetabolicMetabolic syndromeMicroalbuminuriaMorbidity - disease rateObesityOnset of illnessOverweightPediatricsPhysiciansPhysiologic pulsePopulationPrevalenceQuestionnairesRecruitment ActivityResearchResearch PersonnelRiskRisk FactorsRisk MarkerRoleScientistSurrogate MarkersSyndromeTechniquesTestingThickTimeTrainingUltrasonographyUnited StatesUniversitiesWeightWorkYouthabstractingbasecardiovascular disorder riskcardiovascular risk factorcareer developmentin vivoinsulin sensitivityinterestintima mediamortalityobesity in childrenpatient orientedpatient oriented researchpopulation basedprofessorprograms
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Dr. Ingrid Libman is a pediatric endocrinologist with previous training in epidemiology who is currently an Assistant Professor in Pediatrics at the University of Pittsburgh. The candidate's long term goal is to become an academic physician and independent clinical scientist expanding her training from the area of population based epidemiology of childhood diabetes mellitus (DM) to patient oriented and interventional research, with particular focus on the impact of obesity on type 1 diabetes mellitus (T1 DM), in particular on the development of cardiovascular disease (CVD). This interest developed during the last years when Dr. Libman identified an increase in the prevalence of obesity in this population, usually considered not to be overweight. The consequences of this increase are currently not known. Under the mentorships of Drs. Silva Arslanian, Dorothy Becker, Ronald LaPorte and Bradley Keller, Dr. Libman proposes a comprehensive career development plan composed of training in the use of the hyperinsulinemic-euglycemic clamp to assess insulin resistance, measurement of early CVD markers such as carotid ultrasonography to measure intima media thickness and pulse wave velocity and carefully selected course work in clinical patient-oriented research. The research plan is a three year cross sectional study of three groups of children: overweight children with T1DM, non-overweight children with T1DM and overweight children with no DM in order to compare early risk markers of CVD. This study will also assess the role of insulin resistance, measured by the use of the hyperinsulinemic-euglycemic clamp technique in the first two groups, and validate an insulin resistance syndrome score, consisting of clinical parameters which could potentially be used in clinical and population-based studies. This study will recruit 120 children between the ages of 12 and 18 years who will attend the Pediatric Clinical Translational Research Center (PCTRC) for 24 hours to undergo questionnaire, body anthropometry, blood pressure, fasting blood tests, whole body DEXA, carotid ultrasonography and in the groups with diabetes, an hyper insulinemic-euglycemic clamp. Objectives of the study are to 1) test the hypothesis that overweight children with T1 DM have more markers of early atherosclerosis compared to those with T1DM who are not overweight and to those equally overweight with no diabetes and this is mediated by factors which constitute the metabolic syndrome and 2) assess the role of insulin resistance. (End of Abstract)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Application of the Telemedicine for Reach, Education, Access, and Treatment delivery model to engage emerging adults in Diabetes Self-Management Education and Support (TREAT-ED)
-
批准号:10651947
-
项目类别:
-
资助金额:$25.32万
-
财政年份:2023
-
负责人:INGRID M LIBMAN
-
依托单位:
Are Overweight Children with T1DM at Increased Risk of Cardiovascular Disease?
-
批准号:7631138
-
项目类别:
-
资助金额:$13.02万
-
财政年份:2008
-
负责人:INGRID M LIBMAN
-
依托单位:
Are Overweight Children with T1DM at Increased Risk of Cardiovascular Disease?
-
批准号:7470810
-
项目类别:
-
资助金额:$10.01万
-
财政年份:2008
-
负责人:INGRID M LIBMAN
-
依托单位:
"FASTING OR 2-HOUR PLASMA GLUCOSE: BETTER MARKER OF RISK FOR METABOLIC SYNDROME
-
批准号:7203144
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2005
-
负责人:INGRID M LIBMAN
-
依托单位:
EPIDEMIOLOGY OF IDDM IN HISPANIC CHILDREN
-
批准号:2135646
-
项目类别:
-
资助金额:$2.99万
-
财政年份:1994
-
负责人:INGRID M LIBMAN
-
依托单位:
EPIDEMIOLOGY OF IDDM IN HISPANIC CHILDREN
-
批准号:2135644
-
项目类别:
-
资助金额:$2.27万
-
财政年份:1993
-
负责人:INGRID M LIBMAN
-
依托单位:
EPIDEMIOLOGY OF IDDM IN HISPANIC CHILDREN
-
批准号:2135645
-
项目类别:
-
资助金额:$2.86万
-
财政年份:1993
-
负责人:INGRID M LIBMAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: